S 3762 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Prior Authorization Relief Act
To amend part C of title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.
Summary
The Prior Authorization Relief Act amends the Medicare Advantage program to reform prior authorization requirements for high-cost items, services, and drugs. The bill requires the Secretary of Health and Human Services to audit prior authorization requirements by January 1, 2027, and identify items and services that are high-cost, have established clinical evidence, and require excessive prior authorization steps. By May 1, 2028, the Secretary must issue rules to standardize prior authorization requirements for the identified items and services across all Medicare Advantage plans. The bill exempts prior authorization requirements for items and services furnished by providers participating in two-sided risk models, such as accountable care organizations, unless an MA plan specifically requests to maintain prior authorization requirements.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
1 cosponsor
- Sen. Marshall, Roger [R-KS] (R-KS)
Actions (2)
- Feb 3, 2026 Read twice and referred to the Committee on Finance. · senate
- Feb 3, 2026 Introduced in Senate
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Full text
IN THE SENATE OF THE UNITED STATES
February 3, 2026
Mr. Whitehouse introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To amend part C of title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Prior Authorization Relief Act”.
SEC. 2. MEDICARE ADVANTAGE PROGRAM PRIOR AUTHORIZATION REFORMS.
(a) Medicare Advantage.—Section 1859 of the Social Security Act (42 U.S.C. 1395w-28) is amended by adding at the end the following new subsection:
“(j) Prior Authorization Requirements.—
“(1) Audit.—Not later than January 1, 2027, the Secretary shall conduct an audit of prior authorization requirements for items and services furnished, and covered part D drugs prescribed, to enrollees under this part in order to identify the items and services and covered part D drugs that the Secretary determines meet each of the following criteria:
“(A) Reimbursement for such item or service or covered part D drug under this part is in the top 10 percent of reimbursements for all items and services and covered part D drugs under this part.
“(B) There is sufficient clinical evidence to establish a standard medical policy for the prior authorization process for such item or service or covered part D drug.
“(C) Prior authorization for such item or service or covered part D drug requires an excessive number of steps to complete the required protocols.
“(2) Standardized requirements.—Not later than May 1, 2028, taking into account the results of the audit conducted under paragraph (1), the Secretary shall promulgate a final rule to standardize the prior authorization requirements (including supplemental forms) for items and services and covered part D drugs identified under paragraph (1) across all Medicare Advantage plans, including MA-PD plans.
“(3) Exemption from requirements.—
“(A) In general.—Subject to subparagraph (B), the prior authorization requirements under paragraph (2) for the items and services and covered part D drugs identified under paragraph (1) shall not apply when such items and services are furnished by, or such covered part D drugs are prescribed by, a provider of services or supplier that is participating in a two- sided risk model tested or implemented under section 1115A or this title, including an accountable care organization under section 1899, where the model is at risk for both potential losses and gains.
“(B) Limitation.—The Secretary shall establish a process under which an MA organization offering a Medicare Advantage plan (including an MA-PD plan) may request that the exemption under subparagraph (A) not apply with respect to items and services and covered part D drugs furnished to enrollees under the plan and that the prior authorization requirements that would otherwise apply under the plan for such items and services and covered part D drugs continue to apply.”. <all>
Comments